Shanghai Rendu Biotechnology Co Stock

Shanghai Rendu Biotechnology Co Equity Turnover

The Equity Turnover of Shanghai Rendu Biotechnology Co (688193.SS) as of Aug 10, 2026 is 0.19. In the previous year, Equity Turnover was 0.17 — a change of 13.90% (higher).

Equity Turnover

0.19

YoY

13.90%

Last updated:

Equity Turnover of Shanghai Rendu Biotechnology Co is 2026 0.19 . Equity Turnover of Shanghai Rendu Biotechnology Co was 2025 0.17 . It decreases by 13.90% higher compared to the previous year.
Access this data via the Eulerpool API

Shanghai Rendu Biotechnology Co Stock analysis

What does Shanghai Rendu Biotechnology Co do? Shanghai Rendu Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Rendu Biotechnology Co stock

Equity Turnover of Shanghai Rendu Biotechnology Co is 0.19 in 2026.

Equity Turnover of Shanghai Rendu Biotechnology Co changed from 0.17 to 0.19, representing a 13.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Equity Turnover Shanghai Rendu Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

Equity turnover measures how efficiently a company uses shareholders' equity to generate revenue. It is a component of the DuPont analysis framework.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Turnover's Shanghai Rendu Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Equity Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Equity Turnover.

Access this data via the Eulerpool API

Profitability — Shanghai Rendu Biotechnology Co

All Key Metrics — Shanghai Rendu Biotechnology Co